“Matria,” with “A Fantastic Woman” star Daniela Vega, and Raul Camarena’s “The Bus,” with Meraquí Pradis from “Dani Who?,” have both made the cut for December’s Blood Window Lab, the feature project competition at Latin America’s biggest genre movie market.
Part of Ventana Sur, a film-tv market-meet run by the Cannes Festival and Market and Argentina’s Incaa film-tv agency, the Blood Window Lab will be held online for the first time, running Nov. 30-Dec. 4. As state film funding plunges in Brazil and Argentina, 2020’s edition received a record 214 project submissions.
2020’s lineup shows Latin American fantasy genre at least holding up, despite the economic battering taken by many Latin American countries before and during Covid-19.
“Producers and directors are developing strategies to tell stories which are shaped to production realities but still maintain a freshness and do not ignore their social context,” Javier Fernández, head of the Blood Window program,...
Part of Ventana Sur, a film-tv market-meet run by the Cannes Festival and Market and Argentina’s Incaa film-tv agency, the Blood Window Lab will be held online for the first time, running Nov. 30-Dec. 4. As state film funding plunges in Brazil and Argentina, 2020’s edition received a record 214 project submissions.
2020’s lineup shows Latin American fantasy genre at least holding up, despite the economic battering taken by many Latin American countries before and during Covid-19.
“Producers and directors are developing strategies to tell stories which are shaped to production realities but still maintain a freshness and do not ignore their social context,” Javier Fernández, head of the Blood Window program,...
- 10/19/2020
- by John Hopewell and Jamie Lang
- Variety Film + TV
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.